Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/29609
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Young, Marcus | - |
dc.contributor.author | Holmes, Natasha E | - |
dc.contributor.author | Kishore, Kartik | - |
dc.contributor.author | Marhoon, Nada | - |
dc.contributor.author | Amjad, Sobia | - |
dc.contributor.author | Serpa Neto, Ary | - |
dc.contributor.author | Bellomo, Rinaldo | - |
dc.date | 2022-03-23 | - |
dc.date.accessioned | 2022-03-31T22:49:37Z | - |
dc.date.available | 2022-03-31T22:49:37Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Intensive care medicine 2022; 48(5): 559-569 | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/29609 | - |
dc.description.abstract | To compare the prevalence, characteristics, drug treatment for delirium, and outcomes of patients with Natural Language Processing (NLP) diagnosed behavioral disturbance (NLP-Dx-BD) vs Confusion Assessment Method for intensive care unit (CAM-ICU) positivity. In three combined medical-surgical ICUs, we obtained data on demographics, treatment with antipsychotic medications, and outcomes. We applied NLP to caregiver progress notes to diagnose behavioral disturbance and analyzed simultaneous CAM-ICU. We assessed 2313 patients with a median lowest Richmond Agitation-Sedation Scale (RASS) score of - 2 (- 4.0 to - 1.0) and median highest RASS score of 1 (0 to 1). Overall, 1246 (53.9%) patients were NLP-Dx-BD positive (NLP-Dx-BDpos) and 578 (25%) were CAM-ICU positive (CAM-ICUpos). Among NLP-Dx-BDpos patients, 539 (43.3%) were also CAM-ICUpos. In contrast, among CAM-ICUpos patients, 539 (93.3%) were also NLP-Dx-BDpos. The use of antipsychotic medications was highest in patients in the CAM-ICUpos and NLP-Dx-BDpos group (24.3%) followed by the CAM-ICUneg and NLP-Dx-BDpos group (10.5%). In NLP-Dx-BDneg patients, antipsychotic medication use was lower at 5.1% for CAM-ICUpos and NLP-Dx-BDneg patients and 2.3% for CAM-ICUneg and NLP-Dx-BDneg patients (overall P < 0.001). Regardless of CAM-ICU status, after adjustment and on time-dependent Cox modelling, NLP-Dx-BD was associated with greater antipsychotic medication use. Finally, regardless of CAM-ICU status, NLP-Dx-BDpos patients had longer duration of ICU and hospital stay and greater hospital mortality (all P < 0.001). More patients were NLP-Dx-BD positive than CAM-ICU positive. NLP-Dx-BD and CAM-ICU assessment describe partly overlapping populations. However, NLP-Dx-BD identifies more patients likely to receive antipsychotic medications. In the absence of NLP-Dx-BD, treatment with antipsychotic medications is rare. | en |
dc.language.iso | eng | - |
dc.subject | Critical illness | en |
dc.subject | Delirium | en |
dc.subject | Intensive care | en |
dc.subject | Olanzapine | en |
dc.subject | Quetiapine | en |
dc.title | Natural language processing diagnosed behavioral disturbance vs confusion assessment method for the intensive care unit: prevalence, patient characteristics, overlap, and association with treatment and outcome. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Intensive care medicine | en |
dc.identifier.affiliation | Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.. | en |
dc.identifier.affiliation | Data Analytics Research and Evaluation (DARE) Centre | en |
dc.identifier.affiliation | Department of Critical Care, School of Medicine, The University of Melbourne, Parkville, Melbourne, VIC, Australia.. | en |
dc.identifier.affiliation | School of Computing and Information Systems, The University of Melbourne, Parkville, Melbourne, VIC, Australia.. | en |
dc.identifier.affiliation | Intensive Care | en |
dc.identifier.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/35322288/ | en |
dc.identifier.doi | 10.1007/s00134-022-06650-z | en |
dc.type.content | Text | en |
dc.identifier.orcid | http://orcid.org/0000-0002-1650-8939 | en |
dc.identifier.orcid | 0000-0002-6195-660X | en |
dc.identifier.orcid | 0000-0001-8501-4054 | en |
dc.identifier.orcid | 0000-0003-1520-9387 | en |
dc.identifier.pubmedid | 35322288 | - |
local.name.researcher | Bellomo, Rinaldo | |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Journal Article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
crisitem.author.dept | Infectious Diseases | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
crisitem.author.dept | Intensive Care | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
crisitem.author.dept | Intensive Care | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
crisitem.author.dept | Intensive Care | - |
crisitem.author.dept | Data Analytics Research and Evaluation (DARE) Centre | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.